Pharmaceutics
(Jul 2016)
Drug Delivery Approaches for the Treatment of Cervical Cancer
Farideh Ordikhani,
Mustafa Erdem Arslan,
Raymundo Marcelo,
Ilyas Sahin,
Perry Grigsby,
Julie K. Schwarz,
Abdel Kareem Azab
Affiliations
Farideh Ordikhani
Department of Radiation Oncology, Cancer Biology Division, Washington University School of Medicine, Saint Louis, MO 63108, USA
Mustafa Erdem Arslan
Department of Radiation Oncology, Cancer Biology Division, Washington University School of Medicine, Saint Louis, MO 63108, USA
Raymundo Marcelo
Department of Radiation Oncology, Cancer Biology Division, Washington University School of Medicine, Saint Louis, MO 63108, USA
Ilyas Sahin
Department of Medicine, Mount Auburn Hospital, Harvard Medical School, Cambridge, MA 02138, USA
Perry Grigsby
Department of Radiation Oncology, Radiology and Obstetrics and Gynecology, Washington University School of Medicine, Saint Louis, MO 63108, USA
Julie K. Schwarz
Department of Radiation Oncology, Cancer Biology Division, Washington University School of Medicine, Saint Louis, MO 63108, USA
Abdel Kareem Azab
Department of Radiation Oncology, Cancer Biology Division, Washington University School of Medicine, Saint Louis, MO 63108, USA
DOI
https://doi.org/10.3390/pharmaceutics8030023
Journal volume & issue
Vol. 8,
no. 3
Abstract
Read online
Cervical cancer is a highly prevalent cancer that affects women around the world. With the availability of new technologies, researchers have increased their efforts to develop new drug delivery systems in cervical cancer chemotherapy. In this review, we summarized some of the recent research in systematic and localized drug delivery systems and compared the advantages and disadvantages of these methods.
Keywords
WeChat QR code
Close
